112 related articles for article (PubMed ID: 31447246)
1. The prolactin inducible protein/gross cystic disease fluid protein-15 deficient mice develop anomalies in lymphoid organs.
Edechi CA; Nasr MR; Karim A; Blanchard AA; Ellison CA; Qui H; Uzonna JE; Myal Y
Immunobiology; 2019 Nov; 224(6):811-816. PubMed ID: 31447246
[TBL] [Abstract][Full Text] [Related]
2. The human breast cancer-associated protein, the prolactin-inducible protein (PIP), regulates intracellular signaling events and cytokine production by macrophages.
Ihedioha O; Blanchard AA; Balhara J; Okwor I; Jia P; Uzonna J; Myal Y
Immunol Res; 2018 Apr; 66(2):245-254. PubMed ID: 29536339
[TBL] [Abstract][Full Text] [Related]
3. Prolactin-Inducible Protein: From Breast Cancer Biomarker to Immune Modulator-Novel Insights from Knockout Mice.
Ihedioha OC; Shiu RP; Uzonna JE; Myal Y
DNA Cell Biol; 2016 Oct; 35(10):537-541. PubMed ID: 27602994
[TBL] [Abstract][Full Text] [Related]
4. Generation and initial characterization of the prolactin-inducible protein (PIP) null mouse: accompanying global changes in gene expression in the submandibular gland.
Blanchard A; Nistor A; Castaneda FE; Martin D; Hicks GG; Amara F; Shiu RP; Myal Y
Can J Physiol Pharmacol; 2009 Oct; 87(10):859-72. PubMed ID: 20052012
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice.
Li J; Liu D; Mou Z; Ihedioha OC; Blanchard A; Jia P; Myal Y; Uzonna JE
Eur J Immunol; 2015 Apr; 45(4):1082-91. PubMed ID: 25594453
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene.
Myal Y; Iwasiow B; Yarmill A; Harrison E; Paterson JA; Shiu RP
Endocrinology; 1994 Oct; 135(4):1605-10. PubMed ID: 7925123
[TBL] [Abstract][Full Text] [Related]
7. Prolactin-induced protein (PIP)-characterization and role in breast cancer progression.
Urbaniak A; Jablonska K; Podhorska-Okolow M; Ugorski M; Dziegiel P
Am J Cancer Res; 2018; 8(11):2150-2164. PubMed ID: 30555735
[TBL] [Abstract][Full Text] [Related]
8. Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice.
Myal Y; Iwasiow B; Cosby H; Yarmill A; Blanchard A; Tsuyuki D; Fresnoza A; Duckworth ML; Shiu RP
J Mol Endocrinol; 1998 Oct; 21(2):217-23. PubMed ID: 9801465
[TBL] [Abstract][Full Text] [Related]
9. Identification of mouse submaxillary gland protein in mouse saliva and its binding to mouse oral bacteria.
Lee B; Bowden GH; Myal Y
Arch Oral Biol; 2002 Apr; 47(4):327-32. PubMed ID: 11922875
[TBL] [Abstract][Full Text] [Related]
10. The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation.
Myal Y; Robinson DB; Iwasiow B; Tsuyuki D; Wong P; Shiu RP
Mol Cell Endocrinol; 1991 Sep; 80(1-3):165-75. PubMed ID: 1955075
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer.
Sauer N; Matkowski I; Bodalska G; Murawski M; Dzięgiel P; Calik J
Cells; 2023 Sep; 12(18):. PubMed ID: 37759471
[TBL] [Abstract][Full Text] [Related]
12. Expression of the mouse homologue for the human GCDFP-15/PIP gene during pre- and early post-natal development.
Lee B; Modha G; Watson PH; Dodd J; Troup S; Blanchard A; Myal Y
Mol Cell Endocrinol; 2003 Jul; 205(1-2):33-41. PubMed ID: 12890565
[TBL] [Abstract][Full Text] [Related]
13. Indirect IL-4 pathway in type 1 immunity.
Karulin AY; Hesse MD; Yip HC; Lehmann PV
J Immunol; 2002 Jan; 168(2):545-53. PubMed ID: 11777945
[TBL] [Abstract][Full Text] [Related]
14. The Prolactin Inducible Protein Modulates Antitumor Immune Responses and Metastasis in a Mouse Model of Triple Negative Breast Cancer.
Edechi CA; Ikeogu NM; Akaluka GN; Terceiro LEL; Machado M; Salako ES; Barazandeh AF; Kung SKP; Uzonna JE; Myal Y
Front Oncol; 2021; 11():639859. PubMed ID: 33777801
[TBL] [Abstract][Full Text] [Related]
15. Immune system development and function in prolactin receptor-deficient mice.
Bouchard B; Ormandy CJ; Di Santo JP; Kelly PA
J Immunol; 1999 Jul; 163(2):576-82. PubMed ID: 10395643
[TBL] [Abstract][Full Text] [Related]
16. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.
Clark JW; Snell L; Shiu RP; Orr FW; Maitre N; Vary CP; Cole DJ; Watson PH
Br J Cancer; 1999 Nov; 81(6):1002-8. PubMed ID: 10576657
[TBL] [Abstract][Full Text] [Related]
17. Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate.
Tian W; Osawa M; Horiuchi H; Tomita Y
Cancer Sci; 2004 Jun; 95(6):491-5. PubMed ID: 15182429
[TBL] [Abstract][Full Text] [Related]
18. Histopathological and immunohistological analyses in IgA deficient lymphoplasia (aly/aly) mouse.
Komiyama K; Sato J; Okaue M; Goto T; Horimoto S; Akagi T; Akima S; Moro I
J Oral Sci; 2001 Jun; 43(2):91-6. PubMed ID: 11515603
[TBL] [Abstract][Full Text] [Related]
19. Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications.
Hassan MI; Waheed A; Yadav S; Singh TP; Ahmad F
Cell Mol Life Sci; 2009 Feb; 66(3):447-59. PubMed ID: 18854942
[TBL] [Abstract][Full Text] [Related]
20. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
